Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Endometrial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04865289
What this trial is testing

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study

Who this might be right for
Endometrial Neoplasms
Merck Sharp & Dohme LLC 130
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT02506816
What this trial is testing

Preoperative Olaparib Endometrial Carcinoma Study (POLEN)

Who this might be right for
Endometrial Carcinoma
MedSIR 36
Testing effectiveness (Phase 2)Study completedNCT04080284
What this trial is testing

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Who this might be right for
Endometrial CancerPapillary Serous Endometrial CarcinomaUterine Serous Carcinoma+2 more
Northwell Health 22
Not applicableLooking for participantsNCT06549855
What this trial is testing

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrioid CarcinomaMismatch Repair Deficiency
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Ended earlyNCT04577963
What this trial is testing

Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors

Who this might be right for
Triple Negative Breast CancerEndometrial CancerSolid Tumor, Unspecified, Adult+1 more
Hutchmed 52
Post-approval studies (Phase 4)Study completedNCT06049693
What this trial is testing

Iron Prehabilitation in Endometrial Cancer

Who this might be right for
Endometrial CancerPerioperative ComplicationPrehabilitation
National and Kapodistrian University of Athens 156
Not applicableUnknownNCT04894552
What this trial is testing

Complications of Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy for Endometrial Carcinoma

Who this might be right for
Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy
Ain Shams Maternity Hospital 20
Large-scale testing (Phase 3)Study completedNCT03603184
What this trial is testing

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Who this might be right for
Endometrial Cancer
Mario Negri Institute for Pharmacological Research 549
Testing effectiveness (Phase 2)Study completedNCT03926936
What this trial is testing

FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

Who this might be right for
Endometrial Stromal SarcomaAdenosarcoma of UterusLeiomyosarcoma Uterus+3 more
Frederic Amant 17
Not applicableUnknownNCT06279832
What this trial is testing

Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.

Who this might be right for
Endometrial Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,000
Early research (Phase 1)Study completedNCT02269293
What this trial is testing

Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers

Who this might be right for
Ovarian CancerEndometrial Cancer
Memorial Sloan Kettering Cancer Center 23
Not applicableUnknownNCT05227898
What this trial is testing

Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer

Who this might be right for
Cancer
Blue Note Therapeutics 352
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Not applicableStudy completedNCT01430208
What this trial is testing

A New Alternative to Traditional Hysteroscopy

Who this might be right for
Intrauterine DiseasesMyomasPolyps
Catholic University of the Sacred Heart 401
Not applicableStudy completedNCT04000880
What this trial is testing

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

Who this might be right for
Breast CancerColorectal CancerEndometrial Cancer+6 more
University of Alabama at Birmingham 603
Testing effectiveness (Phase 2)Study completedNCT03276013
What this trial is testing

Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Vall d'Hebron Institute of Oncology 48
Next Page